Tinavi Medical Technologies Co., Ltd. (SHA:688277)
China flag China · Delayed Price · Currency is CNY
13.18
-0.78 (-5.59%)
Nov 17, 2026, 3:00 PM CST

SHA:688277 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
229.36264.15260.2310.86211.39287.11
Short-Term Investments
--26.6---
Trading Asset Securities
13.5141.65-50.0440.2120.63
Cash & Short-Term Investments
242.87305.8286.79360.9251.59407.74
Cash Growth
-30.16%6.63%-20.53%43.45%-38.30%-43.42%
Accounts Receivable
47.8842.0270.9649.6635.3737.52
Other Receivables
10.5810.3412.539.5211.8510.16
Receivables
58.4652.3683.4959.1847.2347.68
Inventory
71.8347.2931.6726.2343.837.94
Prepaid Expenses
----2.992.75
Other Current Assets
39.8537.4536.0242.4927.811.3
Total Current Assets
413.01442.89437.97488.8373.41507.42
Property, Plant & Equipment
435.4430.39422.67450.35279.47112.35
Long-Term Investments
593.14617.67596.02454.34467.02265.22
Other Intangible Assets
35.8741.9116.3410.286.697.61
Long-Term Accounts Receivable
-15.728.251.65-3.41
Long-Term Deferred Tax Assets
9.349.1454.1977.878654.16
Long-Term Deferred Charges
35.6515.3232.5413.8519.3820.23
Other Long-Term Assets
156.86141.3123.73122.34174.98308.64
Total Assets
1,6791,7141,6921,6191,4071,279

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
45.9844.5527.8427.7922.529.63
Accrued Expenses
8.5931.9535.6543.1753.7337.83
Short-Term Debt
2016.3825.7832.81--
Current Portion of Long-Term Debt
33.3221.218.1920.683.29-
Current Portion of Leases
-1.923.944.933.4722.59
Current Income Taxes Payable
2.43-----
Current Unearned Revenue
36.7642.1538.6617.6132.1131.56
Other Current Liabilities
3.465.436.5320.0813.2611.62
Total Current Liabilities
150.53163.58156.6167.04158.38113.23
Long-Term Debt
149.84154.25150.37157.7521.25-
Long-Term Leases
4.053.350.263.7540.4148.17
Long-Term Unearned Revenue
0.951.537.214.3111.820.7
Long-Term Deferred Tax Liabilities
53.3453.6157.8942.2552.3722.56
Other Long-Term Liabilities
118.92112.0139.246.855.186.82
Total Liabilities
477.63488.34411.58381.95289.39211.48

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
466.44455.99449.39449.39419.85419.85
Additional Paid-In Capital
1,2171,1431,0451,031668.47670.68
Retained Earnings
-830.88-735.36-551.92-467.22-310.83-192.12
Comprehensive Income & Other
321322.47325.47224.81266.2108.54
Total Common Equity
1,1741,1861,2681,2381,0441,007
Minority Interest
27.6739.5212.29-73.8860.62
Shareholders' Equity
1,2021,2261,2801,2381,1181,068
Total Liabilities & Equity
1,6791,7141,6921,6191,4071,279

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
207.21197.09198.54219.8998.4270.76
Net Cash (Debt)
35.66108.7188.25141.01153.17336.98
Net Cash Growth
-73.80%23.18%-37.42%-7.94%-54.55%-53.24%
Net Cash Per Share
0.080.240.200.320.360.80
Filing Date Shares Outstanding
429.9455.99449.39449.39419.85419.85
Total Common Shares Outstanding
429.9455.99449.39449.39419.85419.85
Working Capital
262.48279.31281.37321.76215.03394.19
Book Value Per Share
2.732.602.822.752.492.40
Tangible Book Value
1,1381,1451,2521,2271,037999.34
Tangible Book Value Per Share
2.652.512.782.732.472.38
Buildings
-365.15364.64360.55132.86-
Machinery
-152.53118.95110.43108.4763.3
Construction In Progress
---10.13--